Altered catecholamine synthesis and degradation in the epidermis of patients with atopic eczema

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Archives of Dermatological Research

• Publication date

  1997-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s004030050258PMID 9452885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased monoamine oxidase A activity in the epidermis of patients with vitiligo

  2006cited by this paper
• High density of beta2-adrenoceptors in a human keratinocyte cell line with complete epidermal differentiation capacity (HaCaT)

  2004cited by this paper
• Catecholamines in human keratinocyte differentiation.

  1995cited by this paper
• Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin.

  1994cited by this paper
• Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo.

  1994cited by this paper
• Binding of beta-adrenergic receptors in human skin.

  1992cited by this paper
• Production of catecholamines in the human epidermis.

  1992cited by this paper
• Tetrahydro‐6‐biopterin is associated with tetrahydro‐7‐biopterin in primary murine mast cells

  1992cited by this paper
• Role of Cyclic Nucleotide Metabolism in the Pathophysiology of Atopic Eczema

  1991cited by this paper
• Analysis of the tetrahydrobiopterin synthesizing system during maturation of murine reticulocytes

  1990cited by this paper
• A sensitive radioenzymatic assay for epinephrine forming enzymes.

  1988cited by this paper
• Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum‐free medium: Clonal analyses, growth kinetics, and cell cycle studies

  1984cited by this paper
• Electrochemical detection of catecholamines in urine and plasma after separation with HPLC.

  1984cited by this paper
• Characterization of the beta-adrenergic receptors of cultured human epidermal keratinocytes.

  1983cited by this paper
• Characterization of β-adrenoreceptors on intact circulating lymphocytes from patients with atopic dermatitis

  1980cited by this paper
• Development of benzylamine oxidase and monoamine oxidase A and B in man.

  1980cited by this paper
• Beta adrenergic receptor binding on polymorphonuclear leukocytes in atopic dermatitis.

  1979cited by this paper
• A new spectrophotometric assay for protein in cell extracts.

  1977cited by this paper
• The cholinergic nervous system and immediate hypersensitivity. 1. Eccrine sweat responses in allergic patients.

  1976cited by this paper
• THE ADENYL CYCLASE OE SKIN II. ADENYL CYCLASE LEVELS IN ATOPIC DERMATITIS

  1970cited by this paper
• Catechol-O-methyl transferase in skin of patients with atopic dermatitis.

  1969cited by this paper
• The beta adrenergic theory of the atopic abnormality in bronchial asthma

  1968influential reference
• Suction blister device for separation of viable epidermis from dermis.

  1968cited by this paper
• Skin reactions to iontophoretically administered epinephrine and norepinephrine in atopic dermatitis.

  1961cited by this paper

• THE REGULATORY EFFECTS OF VITAMINS A, B1, B2, B3, B12, C, D AND E ON SKIN HEALTH, IMMUNITY AND DISEASES

  2025cites this paper
• Atopic Dermatitis and Food Allergy: More Than Sensitization.

  2024cites this paper
• Alterations in Brain Neural Network and Stress System in Atopic Dermatitis: Novel Therapeutic Interventions

  2023cites this paper
• Neuroendocrine Aspects of Skin Aging

  2019cites this paper
• How UV Light Touches the Brain and Endocrine System Through Skin, and Why

  2018cites this paper
• The role of Beta-adrenoceptor (βAR) antagonists in promoting healing of chronic wounds

  2018cites this paper
• Melatonin, mitochondria, and the skin

  2017cites this paper
• Cyclic Adenosine Monophosphate Signaling in Inflammatory Skin Disease

  2015cites this paper
• On the role of skin in the regulation of local and systemic steroidogenic activities.

  2015cites this paper
• Functional interpretation of metabolomics data as a new method for predicting long-term side effects: treatment of atopic dermatitis in infants

  2014cites this paper
• Reduced skin reactivity to vasoconstrictor and vasodilator substances in atopic eczema.

  2013cites this paper
• Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.

  2012cites this paper
• Biogenic Amines in the Skin

  2012cites this paper
• Atopic Dermatitis and the Nervous System

  2011cites this paper
• Neuroimmunology of Atopic Dermatitis

  2009cites this paper
• Neuroimmunology Of The Skin

  2009cites this paper
• Regulation of Cutaneous Immunity by Catecholamines

  2009cites this paper
• Psychoneuroimmunology

  2008cites this paper
• Stress and Immunity

  2008cites this paper
• Structural and functional alterations in the β2‐adrenoceptor are caused by a point mutation in patients with atopic eczema

  2007cites this paper
• Structural and functional alterations in the beta2-adrenoceptor are caused by a point mutation in patients with atopic eczema.

  2007cites this paper
• Beta adrenergic receptors in keratinocytes.

  2007cites this paper
• Lessons Learned … and Relearned: A Busy Clinician Addresses the Psychopharmacology of ADHD in “Real Life”

  2006cites this paper
• Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance.

  2006influential citation
• Update reviews Role of vasculature in atopic dermatitis

  2006cites this paper
• Role of vasculature in atopic dermatitis.

  2006cites this paper
• Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation.

  2005cites this paper
• b-Arrestin2 functions as a phosphorylation- regulated suppressor of UV-induced NF-jB activation

  2005cites this paper
• β‐Arrestin2 functions as a phosphorylation‐regulated suppressor of UV‐induced NF‐κB activation

  2005cites this paper
• Without nerves, immunology remains incomplete –in vivo veritas

  2005cites this paper
• Treatment of Atopic Dermatitis and Psoriasis Vulgaris With Bupropion-SR: A Pilot Study

  2002cites this paper
• What exactly is "atopy"?

  1998cites this paper
• Controversies in Experimental Dermatology: What exactly is “atopy”?

  1998cites this paper